Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Blood. Volume 116, Issue 23: p.4874-4884, 10 August 2010, 10.1182/blood-2009-08-239681

To resolve the genetic heterogeneity within pediatric high-risk B-precursor acute lymphoblastic leukemia (ALL), a clinically defined poor-risk group with few known recurring cytogenetic abnormalities, we performed gene expression profiling in a cohort of 207 uniformly treated children with high-risk ALL. Expression profiles were correlated with genome-wide DNA copy number abnormalities and clinical and outcome features. Unsupervised clustering of gene expression profiling data revealed 8 unique cluster groups within these high-risk ALL patients, 2 of which were associated with known chromosomal translocations (t(1;19)(TCF3-PBX1) or MLL), and 6 of which lacked any previously known cytogenetic lesion. One unique cluster was characterized by high expression of distinct outlier genes AGAP1, CCNJ, CHST2/7, CLEC12A/B, and PTPRM; ERG DNA deletions; and 4-year relapse-free survival of 94.7% ± 5.1%, compared with 63.5% ± 3.7% for the cohort (P = .01). A second cluster, characterized by high expression of BMPR1B, CRLF2, GPR110, and MUC4; frequent deletion of EBF1, IKZF1, RAG1-2, and IL3RA-CSF2RA; JAK mutations and CRLF2 rearrangements (P < .0001); and Hispanic ethnicity (P < .001) had a very poor 4-year relapse-free survival (21.0% ± 9.5%; P < .001). These studies reveal striking clinical and genetic heterogeneity in high-risk ALL and point to novel genes that may serve as new targets for diagnosis, risk classification, and therapy.

Supplemental Data Files

• GDC Manifests
  • Controlled-Access Data Download Manifest (5 Files)
  • Open-Access Data Download Manifest (17 Files)
• Copy Number Array
  • TARGET ALL P1 Copy Number Array Level 1 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 2 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 3 Data
  • TARGET ALL P1 Copy Number Array Level 4 Data
  • TARGET ALL P1 Copy Number Array Metadata
• Gene Expression
  • TARGET ALL P1 Gene Expression Array Level 1 Data
  • TARGET ALL P1 Gene Expression Array Level 2 Data
  • TARGET ALL P1 Gene Expression Array Level 3 Data
  • TARGET ALL P1 Gene Expression Array Level 4 Data
  • TARGET ALL P1 Gene Expression Array Metadata
• mRNA-Seq
  • TARGET ALL P1 mRNA-seq Level 3 Data
  • TARGET ALL P1 mRNA-seq Level 3 Data (Controlled)
  • TARGET ALL P1 mRNA-seq Metadata
• Kinome
  • TARGET ALL P1 Kinome Metadata
  • TARGET ALL P1 Kinome Level 1 Data (Controlled)
• WGS
  • TARGET ALL P1 and P2 WGS L3 Data
  • TARGET ALL P1 and P2 WGS L3 Data (Controlled)
  • TARGET ALL P1 and P2 WGS L4 Data
  • TARGET ALL P1 and P2 WGS Metadata
• Additional Information
  • TARGET ALL P1 Sample Matrix
  • TARGET ALL P1 ID Mapping Information

Additional Resources

• TARGET ALL P1 at SRA (link is external) NCBI

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT (Download, User's Guide)
   • GDC API (User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal (Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT (Download, User’s Guide)
   • GDC API (User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io